Vaccine Propaganda claiming flu jabs cut heart disease
HOW FLU JABS CAN SLASH RISK OF HEART DISEASE BY A HALF
The annual flu jab could help to fend off Britain’s biggest killer
Monday October 29,2012
By Jo Willey
THE annual flu jab can dramatically slash the chances of developing heart disease, research has shown.
Not only can the vaccination protect against the potentially lethal virus, scientists now say it could be the key to beating Britain’s biggest killer too.
They have found that the annual injection can also reduce the risk of heart attack or stroke by as much as 50 per cent – and cardiac deaths by 40 per cent.
There are almost three million Britons blighted by ill health as they struggle to cope with the debilitating effects of heart disease.
Collectively, heart and circulatory diseases cause more than one in three of all deaths in the UK, accounting for more than 191,000 deaths each year at an estimated cost of £30billion to the economy.
Ellen Mason, senior cardiac nurse at the British Heart Foundation, said: “It’s still unclear exactly why the flu jab may hold extra heart health benefits. What is crystal clear is that the vaccine is hugely important to many people, including those with heart disease.
“Flu can make people with chronic heart disease very ill so that group of patients should always take advantage of their eligibility for an annual flu jab. It’s also a good idea to avoid close contact with friends or relatives who already have the virus.
“If you are a heart patient and do come down with the fl u badly, it’s very important you speak to your doctor straight away.”
Dr Jacob Udell, a cardiologist at Women’s College Hospital and the University of Toronto, and his team looked at published clinical trials on this subject, dating back to the 1960s.
Their findings have been presented to the 2012 Canadian Cardiovascular Congress.
Dr Udell said: “For those who had the flu shot there was a pretty strong risk reduction.”
The flu vaccine provided around a 50 per cent reduction in the risk of a major cardiac event such as heart attack, stroke, or cardiac death, compared with placebo after one year of follow-up.
A similar trend was seen for the flu vaccine reducing death from any cause – approximately 40 per cent.
Dr Udell said the research could also potentially boost use of the vaccine, which he believes is still woefully low.
He said: “The use of the vaccine is still much too low, less than 50 per cent of the general population; it’s even poorly used among health care workers. Imagine if this vaccine could also be a proven way to prevent heart disease.”
Earlier this year, the chief medical officer Professor Dame Sally Davies announced that all British children are to be given the annual flu vaccination in a move that could save thousands of lives.
The scheme, which is expected to be rolled out in 2014, will see all children aged two to 17 given the vaccine through a nasal spray.
Even if just 30 per cent take up the offer, experts say there will be 11,000 fewer hospital admissions and 2,000 fewer deaths each year.
Currently, only the over-65s, pregnant women and people with a serious medical condition, including children, are eligible for a free annual seasonal flu jab.
Other people can pay for a vaccine injection, often available at a pharmacy or even at supermarkets.
The latest findings support the findings of a study by the University of Lincoln in 2010 which concluded people who had the flu jab were 19 per cent less likely to have a heart attack in the 12 months following the vaccination than those who didn’t have a shot.
Niroshan Siriwardena, a professor of primary health care, who led the research, said: “Flu vaccination could be associated with a reduction in the risk of heart attack.
“But the vaccine, in itself, does not create some sort of immunity. But not getting the flu offers protection because fl u may trigger a heart attack.”